2017 Environment, Society and Governance Report
Extracted ESG KPIs
KPIs are organized by ESG aspects.
The types of emissions and respective emissions data.
| Indicator | Unit | 2017 | Report Pages |
|---|---|---|---|
| Amount of COD in wastewater discharged / tonne (General Factory) | 5.5 | 76 | |
| Amount of COD in wastewater discharged / tonne (No. 2 Subsidiary) | 12.1 | 76 | |
| Amount of COD in wastewater discharged/tonne (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 4.17 | 86 | |
| Amount of COD in wastewater discharged/tonne (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 7.2 | 86 | |
| Amount of N-NH3 in wastewater discharged/tonne (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 0.34 | 86 | |
| Amount of N-NH3 in wastewater discharged/tonne (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 0.22 | 86 | |
| Amount of NH3-N in wastewater discharged / tonne (General Factory) | 0.07 | 76 | |
| Amount of NH3-N in wastewater discharged / tonne (No. 2 Subsidiary) | 0.32 | 76 | |
| Amount of nitrogen oxide in exhaust gas emitted / kg (General Factory) | 621.45 | 76 | |
| Amount of nitrogen oxide in exhaust gas emitted / kg (No. 2 Subsidiary) | 956 | 76 | |
| Amount of nitrogen oxide in exhaust gas emitted/kg (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 93.6 | 86 | |
| Amount of particulate matter in exhaust gas emitted / kg (No. 2 Subsidiary) | 46 | 76 | |
| Amount of particulate matter in exhaust gas emitted/kg (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 5592 | 86 | |
| Amount of sulfur dioxide in exhaust gas emitted / kg (No. 2 Subsidiary) | 28 | 76 | |
| Amount of sulfur dioxide in exhaust gas emitted/kg (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 28.8 | 86 | |
| Total amount of non-methane hydrocarbon in exhaust gas emitted/kg (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 945.6 | 86 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2017 | Report Pages |
|---|---|---|---|
| Total greenhouse gas emissions / tonne (General Factory, Direct emission) | 38.92 | 76 | |
| Total greenhouse gas emissions / tonne (General Factory, Indirect emission) | 31625.67 | 76 | |
| Total greenhouse gas emissions / tonne (No. 2 Subsidiary, Direct emission) | 590.45 | 76 | |
| Total greenhouse gas emissions / tonne (No. 2 Subsidiary, Indirect emission) | 1313.1 | 76 | |
| Total greenhouse gas emissions/tonne - Direct emission (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 99.43 | 86 | |
| Total greenhouse gas emissions/tonne - Direct emission (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 4.8 | 86 | |
| Total greenhouse gas emissions/tonne - Indirect emission (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 54.52 | 86 | |
| Total greenhouse gas emissions/tonne - Indirect emission (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 3871.9 | 86 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2017 | Report Pages |
|---|---|---|---|
| Hazardous waste disposal volume/Tonne (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 0.5 | 86 | |
| Hazardous waste disposal volume/Tonne (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 12 | 86 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2017 | Report Pages |
|---|---|---|---|
| General waste disposal volume / Tonne (General Factory) | 378 | 76 | |
| General waste disposal volume / Tonne (No. 2 Subsidiary) | 10 | 76 | |
| General waste disposal volume/Tonne (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 2.7 | 86 | |
| General waste disposal volume/Tonne (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 757.1 | 86 |
Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.
| Indicator | Unit | 2017 | Report Pages |
|---|---|---|---|
| Hazardous waste disposal volume / Tonne (General Factory) | 117.45 | 76 | |
| Hazardous waste disposal volume / Tonne (No. 2 Subsidiary) | 5.35 | 76 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2017 | Report Pages |
|---|---|---|---|
| Comprehensive energy consumption / tonne of standard coal (General Factory) | 11942.43 | 76 | |
| Comprehensive energy consumption / tonne of standard coal (No. 2 Subsidiary) | 950.87 | 76 | |
| Comprehensive energy consumption of Shanghai Pharmaceuticals | tons of standard coal | 119500 | 72 |
| Comprehensive energy consumption/tonne of standard coal (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 339.72 | 86 | |
| Comprehensive energy consumption/tonne of standard coal (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 1625.26 | 86 | |
| Diesel fuel consumption / Tonne (No. 2 Subsidiary) | 10.32 | 76 | |
| Diesel fuel consumption/Tonne (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 19.9 | 86 | |
| Electricity consumption / 10000 kWh (General Factory) | 2934.12 | 76 | |
| Electricity consumption / 10000 kWh (No. 2 Subsidiary) | 186.65 | 76 | |
| Electricity consumption/10000 kWh (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 77.5 | 86 | |
| Electricity consumption/10000 kWh (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 366.01 | 86 | |
| Gasoline consumption/Tonne (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 11.71 | 86 | |
| Liquefied petroleum gas/Tonne (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 1.5 | 86 | |
| Natural Gas (Gaseous) / 10000 cubic meters (General Factory) | 1.8 | 76 | |
| Natural Gas (Gaseous) / 10000 cubic meters (No. 2 Subsidiary) | 27.31 | 76 | |
| Natural Gas (Gaseous)/10000 cubic meters (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 140.43 | 86 | |
| Outsourcing thermal power / Million kJ (General Factory) | 998557 | 76 | |
| Outsourcing thermal power/Million kJ (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 5737.7 | 86 | |
| Outsourcing thermal power/Million kJ (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 35175.65 | 86 | |
| Travel cost savings from video conferences | million RMB | 1.64 | 115 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2017 | Report Pages |
|---|---|---|---|
| Amount of wastewater discharged / 10000 tonnes (General Factory) | 22.39 | 76 | |
| Amount of wastewater discharged / 10000 tonnes (No. 2 Subsidiary) | 5.22 | 76 | |
| Amount of wastewater discharged/10000 tonnes (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 0.83 | 86 | |
| Amount of wastewater discharged/10000 tonnes (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 6 | 86 | |
| Water consumption / 10000 tonnes (General Factory) | 24.89 | 76 | |
| Water consumption / 10000 tonnes (No. 2 Subsidiary) | 5.8 | 76 | |
| Water consumption/10000 tonnes (Shanghai Dehua Traditional Chinese Medicines Co., Ltd.) | 1.39 | 86 | |
| Water consumption/10000 tonnes (Shanghai SPH Xingling Sci. & Tech. Pharmaceutical Co., Ltd.) | 8.76 | 86 |
Description of energy use efficiency target(s) set and steps taken to achieve them.
| Indicator | Unit | 2017 | Report Pages |
|---|---|---|---|
| Comprehensive energy consumption goal assigned by Shanghai Municipal Commission of Economy and Informatization to Shanghai Pharmaceuticals | tons of standard coal | 125000 | 72 |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
| Indicator | Unit | 2015 | 2016 | 2017 | Report Pages |
|---|---|---|---|---|---|
| Bachelor degree (Education composition) | 7628 | 8183 | 8558 | 70 | |
| Doctor degree (Education composition) | 54 | 48 | 53 | 70 | |
| Employee structure - Management (%) | % | 3.8 | 3.58 | 70 | |
| Employee structure - Marketing (%) | % | 11.2 | 11.62 | 70 | |
| Employee structure - Others (%) | % | 39.91 | 40.61 | 70 | |
| Employee structure - Production (%) | % | 11.12 | 10.95 | 70 | |
| Employee structure - Technology (%) | % | 33.81 | 33.24 | 70 | |
| Employees aged 19 and under (%) | % | 30.13 | 30.63 | 33.19 | 69 |
| Employees aged 20-29 (%) | % | 25.23 | 26 | 24.96 | 69 |
| Employees aged 30-39 (%) | % | 24.3 | 24.21 | 23.74 | 69 |
| Employees aged 40-49 (%) | % | 17.38 | 17.32 | 14.91 | 69 |
| Employees aged 50-59 (%) | % | 1.71 | 2.23 | 2.39 | 69 |
| Employees aged 60 and above (%) | % | 0.5 | 0.38 | 0.8 | 69 |
| Female employees | 20280 | 20196 | 20769 | 69 | |
| Headcount | 75821 | 60735 | 60078 | 67 | |
| Higher vocational college (Education composition) | 11808 | 11603 | 12110 | 70 | |
| Male employees | 20893 | 20656 | 21467 | 69 | |
| Market capitalization of Shanghai Pharmaceuticals at year end | RMB billion | 65 | 62 | ||
| Master degree (Education composition) | 867 | 924 | 960 | 70 | |
| Middle-senior managers - Number of people | 1205 | 1168 | 1195 | 71 | |
| On-post employees | 33485 | 34220 | 35558 | 69 | |
| Operating revenue | RMB100 million | 1055.17 | 1207.65 | 1308.47 | 63 |
| Ordinary employees - Number of people | 36148 | 36694 | 37932 | 71 | |
| Other employees | 7688 | 6632 | 6678 | 69 | |
| Percentage of R&D investment | % | 5.22 | 5.4 | 5.27 | 28 |
| Technical secondary school (high school) (Education composition) | 12982 | 11576 | 10985 | 70 | |
| Total assets | RMB100 million, billion RMB | 743.44 | 827.43 | 943.44 | 15, 63 |
| Total employees | 41173 | 40852 | 42236 | 69 |
Employee turnover rate by gender, age group and geographical region.
| Indicator | Unit | 2017 | Report Pages |
|---|---|---|---|
| Operating income | billion RMB | 130.847 | 15 |
Number and rate of work-related fatalities occurred in each of the past three years including the reporting year.
| Indicator | Unit | 2015 | 2016 | 2017 | Report Pages |
|---|---|---|---|---|---|
| Work safety accidents or work-related accidents in the year (number of accidents) | number of accidents | 17 | 16 | 20 | 66 |
Description of occupational health and safety measures adopted, and how they are implemented and monitored.
| Indicator | Unit | 2015 | 2016 | 2017 | Report Pages |
|---|---|---|---|---|---|
| Occupational health-related investment | RMB'000 | 2269.42 | 5353.16 | 3555.97 | 67 |
| Safety education and training | Times | 1594 | 1961 | 1881 | 67 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
| Indicator | Unit | 2015 | 2016 | 2017 | Report Pages |
|---|---|---|---|---|---|
| Number of black belt projects in Lean Six Sigma Management | 18 | 29 | |||
| Others (Education composition) | 7834 | 8518 | 9570 | 70 | |
| R&D expenditure distribution - Quality and efficacy consistency evaluation of generic drugs | % | 49.56 | 48.2 | 35.43 | 28 |
| R&D expenditure distribution - R&D of generic drugs | % | 23.46 | 20.77 | 22.59 | 28 |
| R&D expenditure distribution - R&D of innovative drugs | % | 26.98 | 23.12 | 21.14 | 28 |
| R&D expenditure distribution - Secondary development | % | 7.91 | 20.84 | 28 |
The average training hours completed per employee by gender and employee category.
| Indicator | Unit | 2015 | 2016 | 2017 | Report Pages |
|---|---|---|---|---|---|
| Average duration of video conferences | hours | 2.5 | 115 | ||
| Middle-senior managers - Total training man hours | man hours | 56325 | 57782 | 60108 | 71 |
| Number of people participated in black belt and green belt Lean Six Sigma examinations | people | 340 | 65 | ||
| Number of people participated in relevant Lean Six Sigma training | people | 100 | 65 | ||
| Ordinary employees - Total training man hours | man hours | 1126603 | 1216936 | 1277953 | 71 |
| Total duration of video conferences | hours | 342 | 115 |
Number of suppliers by geographical region.
| Indicator | Unit | 2015 | 2016 | 2017 | Report Pages |
|---|---|---|---|---|---|
| Equity attributable to owners of the Company | billion RMB | 39.676 | 15 | ||
| Production approval | number of approvals | 6 | 1 | 4 | 28 |
Number of products and service related complaints received and how they are dealt with.
| Indicator | Unit | 2015 | 2016 | 2017 | May 2017 | November 2016 | Report Pages |
|---|---|---|---|---|---|---|---|
| Average days from prescription by community physicians to dispensing | days | 1.4 | 2.3 | 38 | |||
| Clinical application | number of applications | 14 | 1 | 6 | 28 | ||
| Clinical approval | number of approvals | 16 | 46 | 5 | 28 | ||
| Highest single-day market value of Shanghai Pharmaceuticals | RMB billion | 77.7 | 62 | ||||
| Number of A-share temporary announcements disclosed | announcements | 55 | 61 | ||||
| Number of H-share announcements and documents disclosed | announcements and documents | 77 | 61 | ||||
| Number of drugs that meet extended prescription requirements | items | 517 | 39 | ||||
| Number of investor invitations made by the company | invitations | 200 | 62 | ||||
| Number of investor questions received via E-interactive Platform of Shanghai Stock Exchange | questions | 32 | 62 | ||||
| Number of periodic reports disclosed | reports | 4 | 61 | ||||
| Number of video conferences held | 137 | 115 |
Description of practices relating to observing and protecting intellectual property rights.
| Indicator | Unit | 2015 | 2016 | 2017 | Report Pages |
|---|---|---|---|---|---|
| Invention patent application | number of applications | 110 | 142 | 142 | 28 |
| Obtain authorization for invention | number of authorizations | 51 | 52 | 50 | 28 |
Description of quality assurance process and recall procedures.
| Indicator | Unit | 2015 | 2016 | 2017 | Report Pages |
|---|---|---|---|---|---|
| Number of drug manufacturers and business enterprises directly affiliated to the Company that signed the 2017 letter of responsibility for quality management | 17 | 29 | |||
| Production application | number of applications | 8 | 6 | 6 | 28 |
Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport).
| Indicator | Unit | 2015 | 2016 | 2017 | Report Pages |
|---|---|---|---|---|---|
| Investment in healthy China and targeted poverty alleviation (Shanghai Pharmaceuticals) | million RMB | 10 | 116 | ||
| Per capita profit | RMB'000 | 10.13 | 11.36 | 12.15 | 70 |
| Per capita sales income | RMB'000 | 256.24 | 295.62 | 305.41 | 70 |
| Ranking in 2016 Top 100 Chinese Enterprise (pharmaceutical industry) | th | 6 | 15 | ||
| Ranking in 2016 Top 20 Industrial Enterprises with Drug R&D Product Line in China | Top | 20 | 15 | ||
| Ranking in 2017 Global 2000 by Forbes (Chinese Edition) | th | 99 | 15 | ||
| Ranking in 2017 Most Admired Chinese Pharmaceutical Companies by Fortune (Chinese Edition) | rd | 3 | 15 | ||
| Ranking in 2017 Top 20 enterprises in chemical R&D strength in China | Top | 20 | 15 | ||
| Ranking in 2017 Top 20 in comprehensive medicine R&D strength in China | Top | 20 | 15 | ||
| Ranking in 2017 Top 50 in medicine R&D strength in China | Top | 50 | 15 | ||
| Ranking in 2017 Top 500 Asia brands (pharmaceutical industry) | st | 1 | 15 | ||
| Ranking in 2017 Top 500 Enterprises of China by Fortune (Chinese Edition) | th | 56 | 15 | ||
| Ranking in Outstanding Brands in Chinese Chemical Pharmaceutical Industry (Export of Active Pharmaceutical Ingredients) | th | 10 | 15 | ||
| Ranking in Outstanding Brands in Chinese Chemical Pharmaceutical Industry (Export of Medicine) | th | 13 | 15 | ||
| Ranking in Top 100 in Chinese pharmacy industry in 2016 by Medicine Economic Newspaper | rd | 3 | 15 | ||
| Ranking in Top 500 Chinese enterprises of 2017 | th | 134 | 15 | ||
| Ranking in Top 500 enterprises in Chinese manufacturing industry in 2017 | th | 45 | 15 | ||
| Ranking in top 10 enterprise groups in Chinese pharmaceutical industry in 2017 | rd | 3 | 15 | ||
| Ranking in top 100 Shanghai enterprises of 2017 | th | 15 | 15 | ||
| Ranking in top 100 enterprises in Shanghai manufacturing industry in 2017 | th | 7 | 15 | ||
| Ranking in top 100 industrial enterprises in comprehensive strength in Chinese chemical pharmaceutical industry in 2017 | nd | 2 | 15 |
The types of emissions and respective emissions data.
| Standard Indicator | Unit | 2017 |
|---|---|---|
| Airborne Particulate Matter (PM) Emissions | kg | 46 |
| NOâ‚“ Emissions | kg | 1670.05 |
| SOâ‚“ Emissions | kg | 28 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2017 |
|---|---|---|
| Direct GHG Emissions (Scope 1) | 38.92 | |
| HFC Emissions | kg | |
| Indirect Energy Emissions (Scope 2) | 1313.1 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2017 |
|---|---|---|
| Total Hazardous Waste | tonne | 13.5 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2017 |
|---|---|---|
| Non-Hazardous Waste Disposed | tonne | 1147.8 |
Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.
| Standard Indicator | Unit | 2017 |
|---|---|---|
| Hazardous Waste Intensity Reduction Percentage Compared to Last Year | % | 95.44 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2017 |
|---|---|---|
| Diesel Fuel Consumption | Tonne | 30.22 |
| Gasoline Consumption | Tonne | 11.71 |
| LPG Consumption | Tonne | 1.5 |
| Natural Gas Consumption | 10000 cubic meters | 29.11 |
| Purchased Electricity | 10000 kWh | 3664.28 |
| Total Direct Energy Consumption | tons of standard coal | 119500 |
| Total Energy Consumption | tons of standard coal | 119500 |
| Total Indirect Energy Consumption | Million kJ | 998557 |
| Total Non-Renewable Fuel Consumption | tons of standard coal | 119500 |
| Total Purchased Energy | Million kJ | 998557 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2017 |
|---|---|---|
| Total Wastewater Discharge | 10000 tonnes | 22.39 |
| Total Water Withdrawal | 10000 tonnes | 8.76 |
| Water Consumption | 10000 tonnes | 24.89 |
Description of energy use efficiency target(s) set and steps taken to achieve them.
| Standard Indicator | Unit | 2017 |
|---|---|---|
| Energy Consumption Reduction Compared to Last Year | tons of standard coal | None |
| Target Energy Consumption Reduction Percentage Compared to Last Year | % | None |
Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.
| Standard Indicator | Unit |
|---|---|
| Packaging Material Consumption (Glass) | pieces |
| Packaging Material Consumption (Metal) | pieces |
| Packaging Material Consumption (Plastic) | million pieces |
| Packaging Material Consumption (Rubber) | pieces |
| Packaging Materials Consumed | sets |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
| Standard Indicator | Unit | 2015 | 2016 | 2017 |
|---|---|---|---|---|
| Number of Bachelor's Degree Employees | employees | 7628 | 8183 | 8558 |
| Number of Doctoral Degree Employees | employees | 54 | 48 | 53 |
| Number of Female Employees | employees | 20280 | 20196 | 20769 |
| Number of Male Employees | employees | 20893 | 20656 | 21467 |
| Number of Master's Degree Employees | employees | 867 | 924 | 960 |
| Number of Total Employees | employees | 41173 | 40852 | 42236 |
| Percentage of Employees Aged 30-50 | % | 41.68 | 41.53 | 38.65 |
| Percentage of Employees Aged Above 50 | % | 2.21 | 2.61 | 3.19 |
| Percentage of Employees Aged Below 30 | % | 55.36 | 56.63 | 58.15 |
| Percentage of Female Employees | % | 49.24 | 49.42 | 49.15 |
| Percentage of Male Employees | % | 50.76 | 50.58 | 50.85 |
Description of occupational health and safety measures adopted, and how they are implemented and monitored.
| Standard Indicator | Unit | 2015 | 2016 | 2017 |
|---|---|---|---|---|
| Health Check Coverage for Employees | % | |||
| Investment in Work Safety | RMB'000 | 2269.42 | 5353.16 | 3555.97 |
| Number of People Receiving Training on Work Safety | Times | 1594 | 1961 | 1881 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
| Standard Indicator | Unit |
|---|---|
| Percentage of Employees Trained | % |
| Total Cost of Training | RMB |
The average training hours completed per employee by gender and employee category.
| Standard Indicator | Unit | 2015 | 2016 | 2017 |
|---|---|---|---|---|
| Total Training Hours | man hours | 1182928 | 1274718 | 1338061 |
Number of suppliers by geographical region.
| Standard Indicator | Unit | 2015 | 2016 | 2017 |
|---|---|---|---|---|
| Number of Production Approvals | number of approvals | 6 | 1 | 4 |
Description of practices relating to observing and protecting intellectual property rights.
| Standard Indicator | Unit | 2015 | 2016 | 2017 |
|---|---|---|---|---|
| Number of Patents Applied | number of applications | 110 | 142 | 142 |
| Number of Patents Granted | number of authorizations | 51 | 52 | 50 |
Resources contributed (e.g. money or time) to the focus area.
| Standard Indicator | Unit |
|---|---|
| Investment in Targeted Poverty Alleviation | RMB |
| Total Social Investment | RMB |